Recent news
2026
Financial Times: ‘I had a superpower’: investors pile into mind-reading brain implants features Axoft
Axoft Introduces Fleuron® WISE, the Latest Addition to its Advanced Polymer Portfolio
Global Trial Accelerators Podcast featuring Matt DeNardo, Chief Product Officer at Axoft
DeviceTalks: Expanding BCI in the Clinic Beyond Motor Decoding: Axoft’s Journey to the Clinic and the Road Ahead in Disorders of Consciousness
MGMT Boston: Interview with The Lantern
MedTech Breakthrough: Axoft Named a 2026 MedTech Breakthrough Award Winner
MedTech Innovator: Axoft selected as part of the 2026 cohort, representing the top 4% of applicants
DeviceTalks: Axoft is building a BCI success story in Massachusetts
Axoft Secures $55M Series A to Advance Clinical Trials Globally for its Bio-Inspired, Implantable Brain-Computer Interface
Axoft Commences New Clinical Research Study with Mass General Brigham
Axoft Materials launches MFD-USF for Microfluidics
2025
Axoft won the Emerging Company of the Year in Medical Tools & Devices award at the 13th Annual NEVY Awards
Massachusetts Administration Awards Axoft $835,000 to Build its Pilot Manufacturing
Axoft made it to TechCrunch Battlefield 200!
Mass Device: Top Five BCI stories of 2025
The Harvard Gazette: Brain implants that don’t leave scars
LSI Alumni Innovator Spotlight: Paul Le Floch
Publication in Nature: Fleuron enables 'Cyborg tadpoles'
Axoft Materials goes live!
Business Wire: Axoft Announces Commercialization of Fleuron, Covered by an Exclusive License Agreement with Stanford University
Mass Device: Axoft completes first human cases with ultrasoft BCI
MedTech Insight: Potential For Soft Neural Implant To Help Coma Patients With Signs Of Brain Activity
2024
2023
Axoft's work on soft neural interfaces published in Nature Nanotechnology
Axoft was nominated as Emerging MedTech Company of the Year by the New England Venture Capital Association!
Axoft has completed the Intel Ignite/US Deep-Tech accelerator program!
Axoft has graduated from the Creative Destruction Lab program!
2022